低分子原薬の連続製造の世界市場

低分子原薬の連続製造の世界市場は2030年までに6億2,940万米ドルに達する見込み

2024年に3億6,110万米ドルと推定される低分子原薬の連続製造の世界市場は、2024年から2030年にかけてCAGR 9.7%で成長し、2030年には6億2,940万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるリアクターは、CAGR 11.5％を記録し、分析期間終了時には1億5,650万米ドルに達すると予測されています。晶析装置セグメントの成長率は、分析期間でCAGR 10.2％と推定されます。

米国市場は9,840万米ドルと推定、中国はCAGR13.5％で成長予測

米国の低分子原薬の連続製造市場は、2024年に9,840万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを13.5%として、2030年までに1億2,980万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.8%と8.6%と予測されています。欧州では、ドイツがCAGR約7.7%で成長すると予測されています。

世界の低分子原薬の連続製造市場- 主要動向と促進要因のまとめ

低分子原薬（API）の連続製造は、医薬品製造における変革の力として登場し、従来のバッチプロセスからの飛躍を提供しています。このシフトは主に、効率性の向上、製品品質の改善、フットプリントの削減、需要変動への適応性の向上に対するニーズによって促進されています。主要製薬企業やCMO（医薬品製造受託機関）は、反応、精製、製剤化をシームレスでエンド・ツー・エンドの生産ワークフローに統合する連続処理システムに積極的に投資しています。一つの大きな動向は、重要な品質属性をリアルタイムでモニターし、ロバストで再現性のあるアウトプットを確保するための高度なプロセス分析技術（PAT）の導入が増加していることです。これは、FDAやEMAといった規制機関が、医薬品の品質と信頼性を向上させる可能性があるため、継続的プロセスの採用を支持するだけでなく、積極的に奨励していることと一致しています。さらに、リアルタイム・リリース・テスト（RTRT）機能が連続ラインに統合されつつあり、製品テストに伴う遅延をさらに最小化しています。

ニッチ医薬品、希少疾病用医薬品、個別化医療などの不安定な需要に対応するため、より機敏な生産ラインを求める企業からの関心が高まっています。連続プロセスは、迅速なスケールアップやスケールダウンを可能にし、資本支出と市場投入までの時間を削減します。もう一つの有力な動向は、製薬製造のデジタル化であり、AIを活用したプロセスの最適化と予測分析が、連続製造のセットアップにますます不可欠になっています。このようなデジタル技術とプロセス技術の融合は、コンプライアンス、トレーサビリティ、効率を確保しながら、オペレーションを合理化しています。さらに、連続製造プラットフォームとモジュール式スキッドベースのシステムを組み合わせたハイブリッド製造モデルが、特に柔軟でスケーラブルな製造が重要な新薬の上市において、人気を集めています。これらの技術が成熟するにつれて、研究開発スケールと商業スケールの製造の区別が曖昧になり、研究室での技術革新から市場投入への迅速な移行が可能になりつつあります。

技術は原薬製造経路をどのように再構築しているのか？

連続製造へのシフトの中心には技術革新があります。フローケミストリー、マイクロリアクター、強化されたユニットオペレーションは、商業生産においてますます採用されるようになっており、より高い反応効率、より少ない溶媒使用量、より持続可能な処理を可能にしています。しばしばばらつきやスケールアップの課題を抱えやすいバッチ処理とは異なり、連続プラットフォームは本質的に、より制御され予測可能です。連続的な晶析や膜ベースの分離のような新しいツールは、連続的な方法を用いて製造できる化学物質や原薬の範囲をさらに広げています。これらのツールは、熱に敏感な化合物の製造や、従来のバッチシステムでは制御が困難な高発熱反応の処理に特に効果的です。

オートメーションと制御システムは、連続的な原薬製造に特有の要求を満たすために進化してきました。機械学習やリアルタイム分析と統合された洗練された制御アーキテクチャは、複数の単位操作のシームレスなオーケストレーションを可能にします。さらに、デジタルツインやシミュレーションモデルなどの先進的なソフトウェアツールの統合により、開発中に必要な実験回数を減らしながら、設計とスケールアップ能力を強化しています。装置ベンダーも急速に技術革新を進めており、より迅速な導入とインフラコストの削減を可能にする、連続処理に適したコンパクトでモジュール化されたシステムを提供しています。こうした開発により、生産プラットフォームの近代化を目指す中堅製薬企業や専門メーカーの参入障壁は大幅に下がっています。さらに、新しいAPIの構造や合成がますます複雑化する中、連続処理システムによって可能になる精度とカスタマイズは、運用上の贅沢品ではなく、戦略上必要なものになりつつあります。

需要はどこから来るのか？主要最終用途の理解

低分子原薬の連続製造の採用は、ブランド医薬品、ジェネリック医薬品、CMOにおける需要の明確なパターンを伴って、いくつかの最終用途セグメントで加速しています。先発医薬品メーカーは、迅速で柔軟な上市とライフサイクル管理戦略をサポートするため、特に治療域の狭い医薬品やカスタマイズされた投与が必要な医薬品に継続的なテクノロジーを活用しています。ジェネリック医薬品の分野では、メーカー各社はコストプレッシャーにさらされており、連続加工は品質やコンプライアンスを損なうことなく、COGS（Cost of Goods-Sold）を下げる道を提供しています。CMOやCDMOにとって、継続的製造は戦略的差別化要因となっており、顧客にプロジェクトの迅速なターンアラウンド、在庫要件の低減、プロセスの堅牢性の強化を提供しています。

また、がん、中枢神経系疾患、希少疾病の適応症で使用されるような、少量で高価値の原薬に対する連続製造の使用も顕著に増加しています。このような治療法では通常、短い製造スケジュールと高い純度レベルが要求されるが、これらはいずれも連続システムによって本質的にサポートされるものです。さらに、政府や公衆衛生機関は、特にCOVID-19パンデミックの際に見られたサプライチェーンの混乱を受け、レジリエンス構築戦略の一環として、必要不可欠な原薬の陸上生産や現地生産を提唱し始めています。このような状況において、コンパクトな連続製造装置は、分散化された局地的生産モデルに理想的です。さらに、この業界では、プロセスの安全性、トレーサビリティ、封じ込めが最重要となる規制物質の開発・製造に、連続プラットフォームの利用が拡大しています。

市場拡大の原動力は？注目される主な促進要因

低分子原薬の連続製造市場の成長は、技術革新、規制当局のサポート、エンドユーズパターンの進化、業務上の必要性に関連するいくつかの要因によってもたらされます。主な成長要因の一つは、原薬の複雑化であり、より精密で制御された合成条件が必要となります。第二に、規制当局が審査・承認の迅速化など、連続生産の導入に向けた明確な道筋とインセンティブを提供しており、これが製薬企業の技術投資を後押ししています。第三に、製薬業界がより個別化された標的療法にシフトするにつれ、バッチ生産よりも連続生産に適した、より小さなバッチサイズと迅速な製品化というダイナミクスが必要とされています。

オペレーションの観点からは、製造コストの削減、サプライチェーンの回復力の向上、高い製品品質の維持というプレッシャーが、主要企業を従来の製造システムの再考へと導いています。連続生産は、特にリアルタイムのモニタリングと最適化のためにAI、IoT、高度なアナリティクスと統合された場合、これらの目標を達成するための明確な道筋を提供します。また、モジュラーシステムやポータブルシステムとの統合が可能なことから、中堅製薬企業や政府支援の製造拠点など、より幅広いユーザー層に連続プラットフォームの適用可能性が広がっています。最後に、オンコロジー、希少疾患、特殊ジェネリック医薬品など、スピード、品質、柔軟性が重要な治療分野からの需要の高まりが、医薬品バリューチェーン全体への継続的製造の広範な展開の触媒として作用しています。

セグメント

装置タイプ（リアクター、晶析装置、ろ過システム、ミキサー、熱交換器、その他の装置タイプ）、ユニットオペレーション（合成ユニットオペレーション、分離・精製ユニットオペレーション、乾燥ユニットオペレーション）、APIタイプ（ジェネリックAPI、革新的API）、エンドユーザー（CMO/CDMOエンドユーザー、製薬企業エンドユーザー、学術・研究機関エンドユーザー）

調査対象企業の例

• AbbVie Inc.
• Ajinomoto Bio-Pharma Services
• Amgen Inc.
• Cambrex Corporation
• Concord Biotech Limited
• Divi's Laboratories Limited
• Eli Lilly and Company
• Evonik Industries AG
• GlaxoSmithKline plc（GSK）
• Hovione
• Kaneka Corporation
• Laurus Labs Limited
• Patheon（Thermo Fisher Scientific）
• Pfizer Inc.
• Piramal Pharma Solutions
• SK pharmteco
• Sterling Pharma Solutions
• Suven Pharmaceuticals Limited
• Syngene International Limited
• Veranova

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Continuous Manufacturing For Small Molecule APIs Market to Reach US$629.4 Million by 2030

The global market for Continuous Manufacturing For Small Molecule APIs estimated at US$361.1 Million in the year 2024, is expected to reach US$629.4 Million by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Reactors, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$156.5 Million by the end of the analysis period. Growth in the Crystallizers segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$98.4 Million While China is Forecast to Grow at 13.5% CAGR

The Continuous Manufacturing For Small Molecule APIs market in the U.S. is estimated at US$98.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$129.8 Million by the year 2030 trailing a CAGR of 13.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Continuous Manufacturing For Small Molecule APIs Market - Key Trends & Drivers Summarized

Continuous manufacturing for small molecule active pharmaceutical ingredients (APIs) has emerged as a transformative force in pharmaceutical production, offering a leap forward from the traditional batch processes. This shift is primarily catalyzed by the need for increased efficiency, better product quality, reduced footprint, and greater adaptability to demand fluctuations. Leading pharmaceutical companies and CMOs (Contract Manufacturing Organizations) are actively investing in continuous processing systems that integrate reaction, purification, and formulation into seamless, end-to-end production workflows. One major trend is the increasing deployment of advanced process analytical technologies (PAT) to monitor critical quality attributes in real-time, ensuring robust and reproducible outputs. This aligns with regulatory bodies such as the FDA and EMA that are not only supportive but actively encouraging the adoption of continuous processes due to their potential to enhance drug quality and reliability. Additionally, real-time release testing (RTRT) capabilities are being integrated into continuous lines, further minimizing delays associated with product testing.

A rising wave of interest can be observed from companies seeking more agile production lines to manage the volatile demands of niche drugs, orphan indications, and personalized medicine. Continuous processes allow rapid scale-up or scale-down, reducing capital expenditure and time-to-market. Another influential trend is the digitalization of pharma manufacturing, with AI-driven process optimization and predictive analytics becoming increasingly integral to continuous manufacturing setups. This convergence of digital and process technologies is streamlining operations while ensuring compliance, traceability, and efficiency. Moreover, hybrid manufacturing models, where continuous platforms are coupled with modular, skid-based systems, are gaining traction-especially for new drug launches where flexible, scalable manufacturing is critical. As these technologies mature, the distinction between R&D-scale and commercial-scale manufacturing is blurring, enabling quicker transitions from laboratory innovation to market availability.

How Is Technology Reshaping API Production Pathways?

Technological innovation lies at the heart of the shift to continuous manufacturing. Flow chemistry, microreactors, and intensified unit operations are increasingly being employed in commercial production, enabling higher reaction efficiency, lower solvent usage, and more sustainable processing. Unlike batch processing, which is often prone to variability and scale-up challenges, continuous platforms are inherently more controlled and predictable. Emerging tools such as continuous crystallization and membrane-based separations have further expanded the range of chemistries and APIs that can be manufactured using continuous methods. These tools are especially effective in producing heat-sensitive compounds or handling highly exothermic reactions, which are difficult to control in traditional batch systems.

Automation and control systems have evolved to meet the specific demands of continuous API manufacturing. Sophisticated control architectures, integrated with machine learning and real-time analytics, allow for the seamless orchestration of multiple unit operations. Additionally, the integration of advanced software tools such as digital twins and simulation models is enhancing design and scale-up capabilities while reducing the number of experimental runs required during development. Equipment vendors are also rapidly innovating, offering compact and modular systems tailored for continuous processing that allow faster deployment and lower infrastructure costs. These developments are significantly lowering the barrier to entry for mid-sized pharmaceutical companies and specialty manufacturers seeking to modernize their production platforms. Furthermore, with new APIs increasingly complex in structure and synthesis, the precision and customization enabled by continuous systems are becoming a strategic necessity rather than an operational luxury.

Where Is Demand Emerging From? Understanding Key End-Use Applications

The adoption of continuous manufacturing for small molecule APIs is accelerating across several end-use segments, with distinct patterns of demand in branded pharmaceuticals, generics, and CMOs. Branded drug manufacturers are leveraging continuous technologies to support rapid, flexible launches and lifecycle management strategies, especially for drugs with narrow therapeutic windows or customized dosing requirements. In the generic space, players are under mounting cost pressure, and continuous processing offers a pathway to lower cost-of-goods-sold (COGS) without compromising quality or compliance. For CMOs and CDMOs, continuous manufacturing has become a strategic differentiator, offering clients faster project turnaround, lower inventory requirements, and enhanced process robustness-all of which translate into competitive advantage in contract bidding.

There is also a marked uptick in the use of continuous manufacturing for low-volume, high-value APIs-such as those used in oncology, CNS disorders, and orphan indications. These therapies typically demand short production timelines and high purity levels, both of which are inherently supported by continuous systems. Furthermore, governments and public health organizations are beginning to advocate for onshore or localized production of essential APIs as part of resilience-building strategies, particularly in the wake of supply chain disruptions witnessed during the COVID-19 pandemic. In this context, compact continuous manufacturing units are ideal for distributed, localized production models. Additionally, the industry is seeing growth in the use of continuous platforms for developing and manufacturing controlled substances, where process security, traceability, and containment are of paramount importance.

What Is Fueling Market Expansion? Key Growth Drivers in Focus

The growth in the continuous manufacturing for small molecule APIs market is driven by several factors related to technological innovation, regulatory support, evolving end-use patterns, and operational imperatives. One of the primary growth drivers is the increasing complexity of APIs, which necessitates more precise and controlled synthesis conditions-capabilities where continuous processes excel. Secondly, regulatory authorities are providing clearer pathways and incentives for continuous production adoption, including accelerated review and approval mechanisms, which is encouraging pharmaceutical firms to invest in the technology. Third, as the pharmaceutical industry shifts towards more personalized and targeted therapies, there is a need for smaller batch sizes and rapid product turnaround-dynamics that are better served by continuous rather than batch production.

From an operational standpoint, the pressure to reduce manufacturing costs, improve supply chain resilience, and maintain high product quality is leading companies to reconsider their legacy production systems. Continuous manufacturing offers a clear path to achieving these goals, especially when integrated with AI, IoT, and advanced analytics for real-time monitoring and optimization. The ability to integrate with modular and portable systems is also expanding the applicability of continuous platforms to a broader set of users, including mid-tier pharmaceutical companies and government-backed manufacturing hubs. Lastly, the rising demand from therapeutic segments like oncology, rare diseases, and specialty generics-where speed, quality, and flexibility are critical-is acting as a catalyst for the wider deployment of continuous manufacturing across the pharmaceutical value chain.

SCOPE OF STUDY:

The report analyzes the Continuous Manufacturing For Small Molecule APIs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Equipment Type (Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers, Other Equipment Types); Unit Operation (Synthesis Unit Operation, Separation and Purification Unit Operation, Drying Unit Operation); API Type (Generic APIs, Innovative APIs); End-Use (CMOs/CDMOs End-Use, Pharmaceutical Companies End-Use, Academic and Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• AbbVie Inc.
• Ajinomoto Bio-Pharma Services
• Amgen Inc.
• Cambrex Corporation
• Concord Biotech Limited
• Divi's Laboratories Limited
• Eli Lilly and Company
• Evonik Industries AG
• GlaxoSmithKline plc (GSK)
• Hovione
• Kaneka Corporation
• Laurus Labs Limited
• Patheon (Thermo Fisher Scientific)
• Pfizer Inc.
• Piramal Pharma Solutions
• SK pharmteco
• Sterling Pharma Solutions
• Suven Pharmaceuticals Limited
• Syngene International Limited
• Veranova

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Continuous Manufacturing For Small Molecule APIs - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Regulatory Support from FDA and EMA Strengthens the Business Case for Continuous API Manufacturing
  • Demand for Cost-Effective, High-Yield Production Propels Transition from Batch to Continuous Processes
  • Growing Complexity and Volume in Generic API Production Drives Adoption of Scalable Continuous Systems
  • Faster Time-to-Market Requirements in Drug Development Spur Investment in Agile API Manufacturing Platforms
  • Integration of PAT (Process Analytical Technology) Enables Real-Time Quality Control and Enhances Process Consistency
  • Focus on Reducing Manufacturing Footprint and Waste Supports Green Chemistry and Continuous Processing
  • Rising Pressure to Increase Supply Chain Resilience and Localize API Production Boosts Continuous Capabilities
  • Advancements in Crystallization, Reaction Kinetics, and Flow Chemistry Improve Commercial Viability
  • Increased Investment from CDMOs Expands Access to Continuous Manufacturing Infrastructure for Small Molecule Clients
  • Push for Flexible Manufacturing Platforms Favors Continuous Systems in Multiproduct Facilities
  • R&D Collaboration Between Pharma Giants and Tech Providers Accelerates Technology Transfer
  • Emergence of Modular Skid-Based Systems Enables Rapid Deployment of Continuous API Lines
  • Patent Expiry Wave in Small Molecules Fuels Demand for Cost-Effective Production Pathways
  • Digital Twins and AI-Powered Process Control Enhance Predictability and Efficiency of Continuous API Production
  • Increased Adoption by Specialty Pharma and Biotechs Creates Demand for Small-Scale Continuous Units
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Continuous Manufacturing For Small Molecule APIs Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Continuous Manufacturing For Small Molecule APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Reactors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Reactors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Reactors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Crystallizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Crystallizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Crystallizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Filtration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Filtration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Filtration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Mixers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Mixers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Mixers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Heat Exchangers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Heat Exchangers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Heat Exchangers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Equipment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Equipment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Equipment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Generic APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Generic APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Generic APIs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Innovative APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Innovative APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Innovative APIs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for CMOs / CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for CMOs / CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for CMOs / CDMOs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Synthesis Unit Operation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Synthesis Unit Operation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Synthesis Unit Operation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Separation & Purification Unit Operation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Separation & Purification Unit Operation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Separation & Purification Unit Operation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Drying Unit Operation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Drying Unit Operation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Drying Unit Operation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• JAPAN
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• CHINA
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• EUROPE
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• FRANCE
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• GERMANY
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• INDIA
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030
• AFRICA
  • Continuous Manufacturing For Small Molecule APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Equipment Type - Percentage Breakdown of Value Sales for Reactors, Crystallizers, Filtration Systems, Mixers, Heat Exchangers and Other Equipment Types for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Continuous Manufacturing For Small Molecule APIs by API Type - Generic APIs and Innovative APIs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by API Type - Percentage Breakdown of Value Sales for Generic APIs and Innovative APIs for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Continuous Manufacturing For Small Molecule APIs by End-Use - CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by End-Use - Percentage Breakdown of Value Sales for CMOs / CDMOs End-Use, Pharmaceutical Companies End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Continuous Manufacturing For Small Molecule APIs by Unit Operation - Percentage Breakdown of Value Sales for Synthesis Unit Operation, Separation & Purification Unit Operation and Drying Unit Operation for the Years 2015, 2025 & 2030

IV. COMPETITION